Impact of infective versus sterile transvenous lead removal on 30-day outcomes in cardiac implantable electronic devices. Posted on April 12th, 2024 by LEADconnection Post navigation Previous: Pacing and Defibrillation Consideration in the Era of Transcatheter Tricuspid Valve Replacement.Next: Leadless Pacemaker Implantation from the Jugular Vein Ipsilateral to the Dialysis Catheter: Last Resort for Patients with Limited Vascular Routes.
Pacing and Defibrillation Consideration in the Era of Transcatheter Tricuspid Valve Replacement. Posted on April 12th, 2024 by LEADconnection Post navigation Previous: Effects of envelopes on cardiac implantable electronic device pocket healing: A head-to-head preclinical evaluation.Next: Impact of infective versus sterile transvenous lead removal on 30-day outcomes in cardiac implantable electronic devices.
Effects of envelopes on cardiac implantable electronic device pocket healing: A head-to-head preclinical evaluation. Posted on April 12th, 2024 by LEADconnection Post navigation Previous: Transvenous lead extraction safety and efficacy in infected and noninfected patients using mechanical-only tools: Prospective registry from a high-volume centerNext: Pacing and Defibrillation Consideration in the Era of Transcatheter Tricuspid Valve Replacement.